PVLA Competitors & Alternatives
Compare Palvella Therapeutics, Inc with similar stocks in the same industry
Biotechnology
PVLA
Main Stock$142.04
Tradestie Score
40
Market Cap
$699.30M
Analyst Upside
+62.3%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$65.71
|
$2.21B | - | 36 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$24.92
|
$2.18B | - | 50 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$17.00
|
$2.08B | - | 38 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.79
|
$2.02B | - | 26 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.84
|
$2.01B | - | 33 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.73
|
$1.97B | - | 55 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$11.08
|
$1.92B | - | 34 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$93.53
|
$1.92B | - | 46 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$68.62
|
$1.90B | 53.8 | 55 | Compare |
More PVLA Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry